Jump to main content
Jump to site search

Issue 8, 2019
Previous Article Next Article

Synthetic small-molecule RNA ligands: future prospects as therapeutic agents

Author affiliations

Abstract

RNA is one of the most intriguing and promising biological targets for the discovery of innovative drugs in many pathologies and various biologically relevant RNAs that could serve as drug targets have already been identified. Among the most important ones, one can mention prokaryotic ribosomal RNA which is the target of several marketed antibiotics, viral RNAs or oncogenic microRNAs that are tightly involved in the development and progression of various cancers. Oligonucleotides are efficient and specific RNA targeting agents but suffer from poor pharmacodynamic and pharmacokinetic properties. For this reason, a number of synthetic small-molecule ligands have been identified and studied upon screening of chemical libraries or focused design of RNA binders. In this review, we report the most relevant examples of synthetic compounds bearing sufficient selectivity to envisage clinical studies and future therapeutic applications with a particular attention for the main strategies that can be undertaken toward the improvement of selectivity and biological activity.

Graphical abstract: Synthetic small-molecule RNA ligands: future prospects as therapeutic agents

Back to tab navigation

Publication details

The article was received on 31 Mar 2019, accepted on 30 Apr 2019 and first published on 30 Apr 2019


Article type: Review Article
DOI: 10.1039/C9MD00195F
Med. Chem. Commun., 2019,10, 1242-1255

  •   Request permissions

    Synthetic small-molecule RNA ligands: future prospects as therapeutic agents

    A. Di Giorgio and M. Duca, Med. Chem. Commun., 2019, 10, 1242
    DOI: 10.1039/C9MD00195F

Search articles by author

Spotlight

Advertisements